Literature DB >> 28801234

Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling.

Meng Michelle Xu1, Yang Pu2, Dali Han3, Yaoyao Shi4, Xuezhi Cao2, Hua Liang4, Xiang Chen5, Xiao-Dong Li5, Liufu Deng6, Zhijian J Chen5, Ralph R Weichselbaum4, Yang-Xin Fu7.   

Abstract

Inhibition of cytosolic DNA sensing represents a strategy that tumor cells use for immune evasion, but the underlying mechanisms are unclear. Here we have shown that CD47-signal regulatory protein α (SIRPα) axis dictates the fate of ingested DNA in DCs for immune evasion. Although macrophages were more potent in uptaking tumor DNA, increase of DNA sensing by blocking the interaction of SIRPα with CD47 preferentially occurred in dendritic cells (DCs) but not in macrophages. Mechanistically, CD47 blockade enabled the activation of NADPH oxidase NOX2 in DCs, which in turn inhibited phagosomal acidification and reduced the degradation of tumor mitochondrial DNA (mtDNA) in DCs. mtDNA was recognized by cyclic-GMP-AMP synthase (cGAS) in the DC cytosol, contributing to type I interferon (IFN) production and antitumor adaptive immunity. Thus, our findings have demonstrated how tumor cells inhibit innate sensing in DCs and suggested that the CD47-SIRPα axis is critical for DC-driven antitumor immunity.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28801234      PMCID: PMC5564225          DOI: 10.1016/j.immuni.2017.07.016

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  53 in total

1.  Cross-presentation by intercellular peptide transfer through gap junctions.

Authors:  Joost Neijssen; Carla Herberts; Jan Wouter Drijfhout; Eric Reits; Lennert Janssen; Jacques Neefjes
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

Review 2.  Innate immune sensing and signaling of cytosolic nucleic acids.

Authors:  Jiaxi Wu; Zhijian J Chen
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

3.  CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.

Authors:  Siddhartha Jaiswal; Catriona H M Jamieson; Wendy W Pang; Christopher Y Park; Mark P Chao; Ravindra Majeti; David Traver; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

4.  Measuring pH, ROS production, maturation, and degradation in dendritic cell phagosomes using cytofluorometry-based assays.

Authors:  Ariel Savina; Pablo Vargas; Pierre Guermonprez; Ana-Maria Lennon; Sebastian Amigorena
Journal:  Methods Mol Biol       Date:  2010

5.  Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy.

Authors:  Mark P Chao; Chad Tang; Russell K Pachynski; Robert Chin; Ravindra Majeti; Irving L Weissman
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

6.  Mitochondrial DNA-LL-37 Complex Promotes Atherosclerosis by Escaping from Autophagic Recognition.

Authors:  Zhiye Zhang; Ping Meng; Yajun Han; Chuanbin Shen; Bowen Li; Md Abdul Hakim; Xuguang Zhang; Qiumin Lu; Mingqiang Rong; Ren Lai
Journal:  Immunity       Date:  2015-12-08       Impact factor: 31.745

7.  The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Authors:  Stephen B Willingham; Jens-Peter Volkmer; Andrew J Gentles; Debashis Sahoo; Piero Dalerba; Siddhartha S Mitra; Jian Wang; Humberto Contreras-Trujillo; Robin Martin; Justin D Cohen; Patricia Lovelace; Ferenc A Scheeren; Mark P Chao; Kipp Weiskopf; Chad Tang; Anne Kathrin Volkmer; Tejaswitha J Naik; Theresa A Storm; Adriane R Mosley; Badreddin Edris; Seraina M Schmid; Chris K Sun; Mei-Sze Chua; Oihana Murillo; Pradeep Rajendran; Adriel C Cha; Robert K Chin; Dongkyoon Kim; Maddalena Adorno; Tal Raveh; Diane Tseng; Siddhartha Jaiswal; Per Øyvind Enger; Gary K Steinberg; Gordon Li; Samuel K So; Ravindra Majeti; Griffith R Harsh; Matt van de Rijn; Nelson N H Teng; John B Sunwoo; Ash A Alizadeh; Michael F Clarke; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

8.  Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes.

Authors:  Jill Henault; Jennifer Martinez; Douglas R Green; Miguel A Sanjuan; Jeffrey M Riggs; Jane Tian; Payal Mehta; Lorraine Clarke; Miwa Sasai; Eicke Latz; Melanie M Brinkmann; Akiko Iwasaki; Anthony J Coyle; Roland Kolbeck
Journal:  Immunity       Date:  2012-12-06       Impact factor: 31.745

Review 9.  Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity.

Authors:  Franck J Barrat; Keith B Elkon; Katherine A Fitzgerald
Journal:  Annu Rev Med       Date:  2015-11-02       Impact factor: 13.739

10.  The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo.

Authors:  Steven M Blaauboer; Samira Mansouri; Heidi R Tucker; Hatti L Wang; Vincent D Gabrielle; Lei Jin
Journal:  Elife       Date:  2015-04-21       Impact factor: 8.140

View more
  79 in total

Review 1.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases.

Authors:  Tao Gong; Lei Liu; Wei Jiang; Rongbin Zhou
Journal:  Nat Rev Immunol       Date:  2019-09-26       Impact factor: 53.106

2.  The cGAS/STING Pathway Is Important for Dendritic Cell Activation but Is Not Essential to Induce Protective Immunity against Mycobacterium tuberculosis Infection.

Authors:  Fabio V Marinho; Sulayman Benmerzoug; Stephanie Rose; Priscila C Campos; João T Marques; André Báfica; Glen Barber; Bernhard Ryffel; Sergio C Oliveira; Valerie F J Quesniaux
Journal:  J Innate Immun       Date:  2018-05-23       Impact factor: 7.349

3.  eIF2α phosphorylation: A hallmark of immunogenic cell death.

Authors:  Lucillia Bezu; Allan Sauvat; Juliette Humeau; Marion Leduc; Oliver Kepp; Guido Kroemer
Journal:  Oncoimmunology       Date:  2018-02-14       Impact factor: 8.110

4.  Batf3+ DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy.

Authors:  Jing Liu; Elisa A Rozeman; Jake S O'Donnell; Stacey Allen; Lorenzo Fanchi; Mark J Smyth; Christian U Blank; Michele W L Teng
Journal:  Oncoimmunology       Date:  2018-11-22       Impact factor: 8.110

5.  Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance.

Authors:  Vanessa Gauttier; Sabrina Pengam; Justine Durand; Kevin Biteau; Caroline Mary; Aurore Morello; Mélanie Néel; Georgia Porto; Géraldine Teppaz; Virginie Thepenier; Richard Danger; Nicolas Vince; Emmanuelle Wilhelm; Isabelle Girault; Riad Abes; Catherine Ruiz; Charlène Trilleaud; Kerry Ralph; E Sergio Trombetta; Alexandra Garcia; Virginie Vignard; Bernard Martinet; Alexandre Glémain; Sarah Bruneau; Fabienne Haspot; Safa Dehmani; Pierre Duplouye; Masayuki Miyasaka; Nathalie Labarrière; David Laplaud; Stéphanie Le Bas-Bernardet; Christophe Blanquart; Véronique Catros; Pierre-Antoine Gouraud; Isabelle Archambeaud; Hélène Aublé; Sylvie Metairie; Jean-François Mosnier; Dominique Costantini; Gilles Blancho; Sophie Conchon; Bernard Vanhove; Nicolas Poirier
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 6.  Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints.

Authors:  Kristian M Hargadon
Journal:  Clin Transl Med       Date:  2020-01

Review 7.  Engineering Vaccines to Reprogram Immunity against Head and Neck Cancer.

Authors:  Y S Tan; K Sansanaphongpricha; M E P Prince; D Sun; G T Wolf; Y L Lei
Journal:  J Dent Res       Date:  2018-03-13       Impact factor: 6.116

8.  The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.

Authors:  Eslam Mohamed; Rosa A Sierra; Jimena Trillo-Tinoco; Yu Cao; Patrick Innamarato; Kyle K Payne; Alvaro de Mingo Pulido; Jessica Mandula; Shuzhong Zhang; Paul Thevenot; Subir Biswas; Sarah K Abdalla; Tara Lee Costich; Kay Hänggi; Carmen M Anadon; Elsa R Flores; Eric B Haura; Shikhar Mehrotra; Shari Pilon-Thomas; Brian Ruffell; David H Munn; Juan R Cubillos-Ruiz; Jose R Conejo-Garcia; Paulo C Rodriguez
Journal:  Immunity       Date:  2020-04-14       Impact factor: 31.745

9.  Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs.

Authors:  Julie M Diamond; Claire Vanpouille-Box; Sheila Spada; Nils-Petter Rudqvist; Jessica R Chapman; Beatrix M Ueberheide; Karsten A Pilones; Yasmeen Sarfraz; Silvia C Formenti; Sandra Demaria
Journal:  Cancer Immunol Res       Date:  2018-06-15       Impact factor: 11.151

Review 10.  Targeting mitochondria in cancer: current concepts and immunotherapy approaches.

Authors:  Sergey Pustylnikov; Francesca Costabile; Silvia Beghi; Andrea Facciabene
Journal:  Transl Res       Date:  2018-07-31       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.